[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584335":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":30,"centralContacts":37,"locations":47,"responsibleParty":78,"collaborators":30,"id":81,"slug":82,"hasResults":83,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":30,"eligibilityCriteria":87,"healthyVolunteers":88,"sex":89,"minAge":90,"maxAge":91,"enrollmentInfo":92,"targetDuration":30,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":101,"overallStatus":105,"whyStopped":30,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Cairo University","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Gabapentin 600 mg group","ACTIVE_COMPARATOR","21 patients will receive 600 mg oral gabapentin one hour before induction.",[13],"Drug: Gabapentin 600 mg capsules",{"label":15,"type":10,"description":16,"interventionNames":17},"Gabapentin 400 mg group","21 patients will receive 400 mg oral gabapentin one hour before induction.",[18],"Drug: Gabapentin 400 mg capsules",{"label":20,"type":21,"description":22,"interventionNames":23},"control group","PLACEBO_COMPARATOR","21 patients will receive placepo one hour before induction.",[24],"Drug: Placebo",[26,31,34],{"type":27,"name":28,"description":11,"armGroupLabels":29,"otherNames":30},"DRUG","Gabapentin 600 mg capsules",[9],null,{"type":27,"name":32,"description":16,"armGroupLabels":33,"otherNames":30},"Gabapentin 400 mg capsules",[15],{"type":27,"name":35,"description":22,"armGroupLabels":36,"otherNames":30},"Placebo",[20],[38,43],{"name":39,"role":40,"phone":41,"phoneExt":30,"email":42},"maged mobarak mobarak, assisstant lecturer","CONTACT","+0201010282650","magedmubark98@gmail.com",{"name":44,"role":40,"phone":45,"phoneExt":30,"email":46},"Hebatallah Salah Abdelhamid, : Lecturer of anesthesia, ICU","+201004507530","drhebasalah593@gmail.com",[48],{"facility":49,"status":30,"city":50,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"Kasr Elainy Hospital , Cairo University","Cairo","Cairo Governorate","11956","Egypt","EG",{"type":56,"coordinates":57},"Point",[58,59],31.24967,30.06263,{"lat":59,"lon":58},[62,66,69,72,74,76],{"name":63,"role":40,"phone":64,"phoneExt":30,"email":65},"vice dean for community affairs","+20223647545","website@kasralainy.edu.eg",{"name":67,"role":68,"phone":30,"phoneExt":30,"email":30},"maged mobarak abdelkhalek, assistant lecturer of","SUB_INVESTIGATOR",{"name":70,"role":71,"phone":30,"phoneExt":30,"email":30},"Ahmed Ali Badawy, professor of anesthesia","PRINCIPAL_INVESTIGATOR",{"name":73,"role":68,"phone":30,"phoneExt":30,"email":30},"Ashraf Abdelmwgod Ali, professor of anesthesia",{"name":75,"role":68,"phone":30,"phoneExt":30,"email":30},"ahmed farag mohamed, lrcturer",{"name":77,"role":68,"phone":30,"phoneExt":30,"email":30},"hebatalla salah abdelhamid, lecturer",{"type":71,"investigatorFullName":79,"investigatorTitle":80,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"Maged Mobarak Abdelkhalek Abdelfattah","assisstant lecturer","100584335","phase-3-the-effect-of-oral-gabapentin-on-emergence-agitation-and-delirium-in-adult-patients-after-nasal-surgery-100584335",false,"NCT06887998","The Effect of Oral Gabapentin on Emergence Agitation and Delirium in Adult Patients After Nasal Surgery.","The Effect of Two Different Doses of Oral Gabapentin on Sevoflurane-associated Emergence Agitation and Delirium in Adult Patients After Nasal Surgery. A Prospective Controlled, Randomized, Double-blinded Study.","Inclusion Criteria:\n\n* All patients (male\u002Ffemale, American Society of Anesthesiologists physical status I-II, age: 18-60 years) undergoing elective nasal surgery will be eligible for the study.\n\nExclusion Criteria:\n\n1. hypersensitivity to gabapentin\n2. patient refusal\n3. epilepsy\n4. neurological or psychological conditions that impair communication.\n5. current use of gabapentin, psychotropic or opioids medications.",true,"ALL","18 Years","60 Years",{"count":93,"type":94},63,"ESTIMATED","INTERVENTIONAL",[97],"PHASE3","Emergence agitation is a postanesthetic phenomenon that develops in the early phase of recovery from general anesthesia, and is characterized by agitation, disorientation, confusion, and possible violent behavior. Emergence agitation can cause serious events such as self-extubation, bleeding, catheter removal and even falling out of the bed leading to severe injuries . Furthermore, it may lead to injuries to health care providers and increase the demand on human resources.\n\nWhile its pathogenesis remains unclear, previous studies reported that ENT (ear, nose, and throat) surgical procedures have a higher incidence of emergence agitation in both adults and children.\n\nEmergence agitation is a common phenomenon occurring in 22.2% in adult patients undergoing general anesthesia for nasal surgery .\n\nGabapentin, agamma-aminobutyricacidanalog, binds the voltage-gated calcium channels of the dorsal root ganglion, at α2-δ subunite. Gabapentin binding to these channels reduces the release of excitatory neurotransmitters preventing the propagation of painful stimuli which makes its use helpful in treatment of postoperative pain and agitation with less side effects compared with benzodiazepines and opioids . Gabapentin has been used in controlling acute perioperative conditions like preoperative anxiety, intraoperative attenuation of hemodynamic response to noxious stimuli and post operative pain, delirium and nausea and vomiting.\n\nA previous study examined the effect of oral gabapentin 600 mg in reducing emergence agitation in adult patients undergowing rhinoplasty, but this study will examine the effect of two different doses of oral gabapentin 400 mg and 600 mg in reducing emergence agitation after nasal surgery.",[100],"Emergence Agitation",[102,103,104],"emergence agitation","gabapentin","nasal surgery","NOT_YET_RECRUITING","2025-03-19",{"date":108,"type":109},"2025-03-21","ACTUAL",{"date":111,"type":94},"2025-03",{"date":113,"type":94},"2026-03",{"name":5,"class":6},1]